Adjuvant therapy in the treatment of stage II uterine carcinoma

被引：1
|
作者：
Berry, L. K. [1 ]
Harbin, L. M. [1 ]
Buchanan, T. R. [2 ]
Kohler, M. F. [1 ]
Cooper, L. [1 ]
Creasman, W. T. [1 ]
Graybill, W. A. [1 ]
机构：
[1] Med Univ South Carolina, Charleston, SC 29425 USA
[2] Washington Univ, Sch Med St Louis, St Louis, MO USA
来源：
GYNECOLOGIC ONCOLOGY | 2018年 / 149卷 / 03期
关键词：
D O I：
10.1016/j.ygyno.2018.03.019
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
10
引用
收藏
页码：623 / 624
页数：2
相关论文
共 50 条
  • [31] Uterine papillary serous carcinoma: comparisons of outcomes in surgical Stage I patients with and without adjuvant therapy
    Huh, WK
    Powell, M
    Leath, CA
    Straughn, JM
    Cohn, DE
    Gold, MA
    Falkner, CA
    Carey, DE
    Herzog, T
    Fowler, JM
    Partridge, EE
    Kilgore, LC
    Alvarez, RD
    GYNECOLOGIC ONCOLOGY, 2003, 91 (03) : 470 - 475
  • [32] Toxicity after adjuvant therapy for stage III uterine cancer
    Chen, Lillian C.
    Huang, Yongmei
    Hou, June Y.
    Khoury-Collado, Fady
    Melamed, Alexander
    St Clair, Caryn M.
    Tergas, Ana I.
    Hur, Chin
    Hillyer, Grace C.
    Hershman, Dawn L.
    Wright, Jason D.
    GYNECOLOGIC ONCOLOGY, 2020, 159 (03) : 737 - 743
  • [33] Recurrence and survival outcomes following adjuvant therapy for early-stage uterine serous carcinoma (USC).
    Iglesias, David A.
    Holman, Laura L.
    Westin, Shannon Neville
    Fellman, Bryan
    Schmeler, Kathleen M.
    Ramirez, Pedro T.
    Frumovitz, Michael M.
    Lu, Karen H.
    Soliman, Pamela T.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [34] Adjuvant therapy for Stage IA uterine clear cell carcinoma with no myometrial invasion: a critical review of literature
    Desteli, G. A.
    Dogan, N. U.
    Gursu, T.
    Ayhan, A.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2016, 37 (01) : 17 - 21
  • [35] Considering adjuvant therapy for stage II melanoma
    Poklepovic, Andrew S.
    Luke, Jason J.
    CANCER, 2020, 126 (06) : 1166 - 1174
  • [36] Adjuvant radiation therapy for stage II thymoma
    Mangi, AA
    Wright, CD
    Allan, JS
    Wain, JC
    Donahue, DM
    Grillo, HC
    Mathisen, DJ
    ANNALS OF THORACIC SURGERY, 2002, 74 (04): : 1033 - 1037
  • [37] Adjuvant therapy of stage II colorectal cancer – who will benefit from treatment?
    H. Zwierzina
    memo - Magazine of European Medical Oncology, 2008, 1 (2) : 75 - 77
  • [38] Adjuvant therapy of stage II colorectal cancer - who will benefit from treatment?
    Zwierzina, H.
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2008, 1 (02) : 75 - 77
  • [39] Treatment With Adjuvant Pelvic Radiation Therapy ± Vaginal Brachytherapy in Patients With High-Risk Stage I or Stage II Uterine Papillary Serous, Clear Cell, and High-Grade Endometrioid Carcinoma
    Nagar, H.
    Yan, W.
    Parashar, B.
    Nori, D.
    Chao, K.
    Christos, P.
    Gupta, D.
    Holcomb, K.
    Caputo, T.
    Wemicke, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S492 - S492
  • [40] A multi-institutional cohort study of adjuvant therapy in stage I-II uterine carcinosarcoma
    Cantrell, Leigh A.
    Havrilesky, Laura
    Moore, Dominic T.
    O'Malley, David
    Liotta, Margaret
    Secord, Angeles Alvarez
    Nagel, Christa I.
    Cohn, David E.
    Fader, Amanda Nickles
    Wallace, Amy H.
    Rose, Peter
    Gehrig, Paola A.
    GYNECOLOGIC ONCOLOGY, 2012, 127 (01) : 22 - 26
12345